-
Founded in:
1998-07-27 -
Country:
China -
Address:
No. 2 Weihai Road, Pingfang Economic and Technological Development Zone, Harbin City, Heilongjiang Province -
Tax NO.:
91230199702846035D -
Registered Funds:
5 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Bovine fetal liver extract |
It contains a variety of liver-derived peptide cytokines such as IGF1, FGF, TGFs, and HGF, which increase the activity of ATP synthase by inducing the glycoprotein receptors on the liver cell membrane and mitochondrial membrane, promote the cell's uptake and utilization of glucose, and increase energy synthesis; promote the combination of fatty acids and apolipoproteins and their entry into the blood, reduce fat accumulation in the liver, promote fatty acid beta-oxidation, and accelerate fat decomposition.
More
It contains a variety of liver-derived peptide cytokines such as IGF1, FGF, TGFs, and HGF, which increase the activity of ATP synthase by inducing the glycoprotein receptors on the liver cell membrane and mitochondrial membrane, promote the cell's uptake and utilization of glucose, and increase energy synthesis; promote the combination of fatty acids and apolipoproteins and their entry into the blood, reduce fat accumulation in the liver, promote fatty acid beta-oxidation, and accelerate fat decomposition. |
0 | ||
| Vitamin B12 |
This product, through the action of cytokines such as IGF1, FGF and inositol, induces the polysaccharide protein receptors of liver cell membranes and mitochondrial membranes, increases the activity of ATP synthase, promotes the cell's uptake and utilization of glucose, and increases energy synthesis. This product can promote the combination of fatty acids and apolipoproteins and their entry into the blood, reduce fat accumulation in the liver, promote fatty acid beta-oxidation, and accelerate fat decomposition.
More
This product, through the action of cytokines such as IGF1, FGF and inositol, induces the polysaccharide protein receptors of liver cell membranes and mitochondrial membranes, increases the activity of ATP synthase, promotes the cell's uptake and utilization of glucose, and increases energy synthesis. This product can promote the combination of fatty acids and apolipoproteins and their entry into the blood, reduce fat accumulation in the liver, promote fatty acid beta-oxidation, and accelerate fat decomposition. |
68-19-9 | 16 | |
| Inositol |
It participates in inducing the glycoprotein receptors on the liver cell membrane and mitochondrial membrane, increasing the activity of ATP synthase, promoting the uptake and utilization of glucose by cells, and increasing energy synthesis.
More
It participates in inducing the glycoprotein receptors on the liver cell membrane and mitochondrial membrane, increasing the activity of ATP synthase, promoting the uptake and utilization of glucose by cells, and increasing energy synthesis. |
87-89-8 | 8 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cervi Cornu Panto Trichum |
|
0 | ||
| Epimedium P.E Icariin 10%,20% HPLC |
|
0 | ||
| Morinda officinalis sky white matrix sample |
|
0 | ||
| REHMANNIAE RADIX PRAEPARATA |
|
0 | ||
| Codonopsis |
|
0 | ||
| Astragali Radix |
|
0 | ||
| lycii Fructus |
|
0 | ||
| Cnidii Fructus |
|
0 | ||
| CERVI CORNUS COLLA |
|
0 | ||
| CHINEMYSREEVESII(GRAY)# |
|
0 | ||
| Asparagus cochinchinensis |
|
0 | ||
| Honey |
|
8028-66-8 | 89 | |
| ethyl salicylate |
|
118-61-6 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| atriopeptin II |
It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.
More
It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis. |
98084-69-6 | 0 | |
| calcitonin gene related peptide |
It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.
More
It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis. |
0 | ||
| Adenosine triphosphate |
It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.
More
It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis. |
56-65-5 | 2 | |
| 5-Methyl-2'-deoxycytidine |
It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.
More
It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis. |
838-07-3 | 0 | |
| Amino acids and their metabolic intermediates |
It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis.
More
It can improve blood circulation disorders, reduce vascular resistance, increase myocardial oxygen utilization, promote the enhancement of hematopoietic system activity, increase the number of white blood cells, and increase vascular elasticity and prevent vascular sclerosis. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Thymosin |
Immunomodulatory drugs have the function of regulating and enhancing the cellular immune function of the human body. They can promote the maturation of T lymphocytes, increase the secretion of various lymphokines by T cells (such as: α, γ interferon, interleukin 2 and interleukin 3), increase the level of lymphokine receptors on T cells, activate T4 helper cells to enhance lymphocyte response, affect the chemotaxis of NK precursor cells and enhance the body's ability to resist radiation.
More
Immunomodulatory drugs have the function of regulating and enhancing the cellular immune function of the human body. They can promote the maturation of T lymphocytes, increase the secretion of various lymphokines by T cells (such as: α, γ interferon, interleukin 2 and interleukin 3), increase the level of lymphokine receptors on T cells, activate T4 helper cells to enhance lymphocyte response, affect the chemotaxis of NK precursor cells and enhance the body's ability to resist radiation. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Clotrimazole |
1. Inhibit plasminogen activators, so that plasminogen cannot be activated into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect; 2. Promote the release of active substances by platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect; 3. Enhance capillary resistance, reduce capillary permeability, and thus reduce bleeding.
More
1. Inhibit plasminogen activators, so that plasminogen cannot be activated into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect; 2. Promote the release of active substances by platelets, enhance platelet aggregation and adhesion, shorten coagulation time, and produce a hemostatic effect; 3. Enhance capillary resistance, reduce capillary permeability, and thus reduce bleeding. |
0 |